WHO’s Draft Pandemic Treaty Calls For More Regulatory Harmonization
Executive Summary
Regulatory convergence and the sharing of dossiers, together with the timely and equitable sharing of pathogens, could help to speed up access to medicines, vaccines and diagnostics in pandemic situations, according to the first draft of the World Health Organization’s proposed pandemic treaty.
You may also be interested in...
COVID Vaccines: What FDA Isn’t Talking About Ahead Of Upcoming Advisory Panel
From next-generation vaccine technology to safety data and global harmonization, what isn’t in the Vaccines and Related Biological Products Advisory Committee preview documents and on the 26 January meeting agenda may be just as important as what is.
Countries To Discuss Pandemic Treaty Next Year Amid Industry Concern
A World Health Organization negotiating body has agreed to develop a “zero draft” of the proposed pandemic treaty for discussion at a meeting of WHO member states in February next year. But the international pharmaceutical industry has reiterated its concerns about some of the proposals being put forward.
First Draft Of WHO’s Pandemic Treaty: IP Waivers, Tech Transfer & Price Transparency
A World Health Organization negotiating body will shortly examine the “zero draft” of a proposed pandemic treaty aimed at better preparing the world for future health crises. But the international pharmaceutical industry claims the draft as currently worded could actually undermine equitable access to pandemic countermeasures.